SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-009439
Filing Date
2022-04-18
Accepted
2022-04-18 07:33:46
Documents
8
Period of Report
2022-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A auriniapharmaceuticalsinc2.htm DEF 14A 1087270
2 GRAPHIC a3yearcharta.jpg GRAPHIC 48001
3 GRAPHIC aurinalogoa.jpg GRAPHIC 11010
4 GRAPHIC backcover_lha.jpg GRAPHIC 38273
5 GRAPHIC fop_1a.jpg GRAPHIC 163446
6 GRAPHIC fop_2a.jpg GRAPHIC 137229
7 GRAPHIC noticegraphic_lha.jpg GRAPHIC 33931
8 GRAPHIC screenshot2022-04x11114537a.jpg GRAPHIC 252901
  Complete submission text file 0001628280-22-009439.txt   2005247
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36421 | Film No.: 22831022
SIC: 2834 Pharmaceutical Preparations